Stockreport

NeuroSense Therapeutics Announces Receipt of Nasdaq Notifications Regarding Minimum Bid Price and Market Value Requirements [Yahoo! Finance]

NeuroSense Therapeutics Ltd. - Ordinary Shares  (NRSN) 
PDF Nasdaq has provided the Company until September 29, 2026 to regain compliance with both requirements The Company is actively evaluating actions to regain compliance, [Read more]